|
|
|
Insider
Information: |
Bradbury Daniel |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
223,469 |
|
Indirect Shares
|
3,161,475 |
|
|
Direct
Value |
$2,427,922 |
|
|
Indirect Value
|
$4,299,408 |
|
|
Total
Shares |
3,384,944 |
|
|
Total
Value |
$6,727,329 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-06 |
4,655 |
2024-05-06 |
9,981 |
Premium* |
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
423 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 17
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ILMN |
Illumina Inc |
Director |
|
2014-10-01 |
4 |
OE |
$42.82 |
$89,922 |
D/D |
2,100 |
14,566 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2014-10-13 |
4 |
OE |
$42.82 |
$89,922 |
D/D |
2,100 |
14,566 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2014-10-30 |
4 |
OE |
$42.82 |
$89,922 |
D/D |
2,100 |
14,566 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2014-11-13 |
4 |
OE |
$42.82 |
$89,922 |
D/D |
2,100 |
14,566 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
|
2007-03-07 |
4 |
AS |
$37.00 |
$92,500 |
I/I |
(2,500) |
5,394 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-09-08 |
4 |
AS |
$44.25 |
$93,412 |
I/I |
(2,111) |
11,296 |
|
- |
|
ILMN |
Illumina Inc |
Director |
|
2015-09-14 |
4 |
OE |
$44.51 |
$94,357 |
D/D |
1,700 |
15,476 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
|
2007-01-09 |
4 |
AS |
$38.51 |
$96,276 |
I/I |
(2,500) |
11,394 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-04-09 |
4 |
AS |
$38.66 |
$96,657 |
I/I |
(2,500) |
1,597 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2017-02-17 |
4 |
AS |
$162.80 |
$97,677 |
D/D |
(600) |
16,465 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2017-03-21 |
4 |
AS |
$163.32 |
$98,134 |
D/D |
(600) |
16,465 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
|
2006-12-07 |
4 |
AS |
$39.35 |
$98,369 |
I/I |
(2,500) |
2,496 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2016-08-17 |
4 |
AS |
$167.66 |
$101,053 |
D/D |
(600) |
16,465 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-04-27 |
4 |
OE |
$7.13 |
$101,132 |
D/D |
14,194 |
41,636 |
|
- |
|
ILMN |
Illumina Inc |
Director |
|
2016-09-14 |
4 |
AS |
$170.40 |
$102,748 |
D/D |
(600) |
16,465 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-08-27 |
4 |
D |
$19.88 |
$103,495 |
D/D |
(5,206) |
26,636 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2004-08-27 |
4 |
OE |
$7.13 |
$103,498 |
D/D |
14,526 |
31,842 |
|
- |
|
ILMN |
Illumina Inc |
Director |
|
2017-04-07 |
4 |
AS |
$172.79 |
$103,675 |
D/D |
(600) |
16,465 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2024-01-05 |
4 |
AS |
$20.36 |
$103,836 |
I/I |
(5,100) |
41,849 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2017-05-25 |
4 |
AS |
$173.28 |
$104,167 |
D/D |
(600) |
15,324 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2009-12-03 |
4 |
AS |
$29.21 |
$105,346 |
D/D |
(3,600) |
4,000 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2016-05-17 |
4 |
D |
$138.77 |
$106,020 |
D/D |
(764) |
13,612 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-09-08 |
4/A |
AS |
$44.25 |
$106,687 |
I/I |
(2,411) |
10,996 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2012-11-21 |
4 |
B |
$1.38 |
$110,504 |
I/I |
80,000 |
80,000 |
2.1 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2016-10-07 |
4 |
AS |
$184.07 |
$110,613 |
D/D |
(600) |
16,465 |
0 |
- |
|
423 Records found
|
|
Page 9 of 17 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|